Status:
UNKNOWN
STIMTAVI : Evolution of Atrioventricular Conduction Disorders After TAVI
Lead Sponsor:
Association de Recherche en Cardiologie des Alpes
Collaborating Sponsors:
LivaNova
Conditions:
Pacemaker Implantation
TAVI
Eligibility:
All Genders
18+ years
Brief Summary
The investigators propose to carry out an observational study of patients implanted with a pacemaker using AAI SafeR® mode after a TAVI procedure. This study aims to define the persistence or not of h...
Detailed Description
Atrioventricular (A-V) conduction disorders are common after Transcatheter Aortic Valve Implantation (TAVI) and the average of a pacemaker implantation after TAVI is 15% to 17%. The European Society ...
Eligibility Criteria
Inclusion
- All patients over 18 years who underwent implantation of a TAVI and that were implanted during the hospitalization with a dual chamber pacemaker Sorin®, set in AAI SafeR ® or AAI SafeR-R® mode.
Exclusion
- Patients with life expectancy at hospital discharge estimated as less than 1 year
- TAVI procedure failure
- Patients refusing to be involved in the study
- Patients implanted with a PM of a brand different than Sorin® during the hospital phase or implanted Sorin® PM but not set in a AAI or AAI SafeR SafeR-R mode
- Patients with PM implant before TAVI
- Permanent AF at the implantation time
- Patients with Single or Triple chamber PM
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 19 2018
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT03338582
Start Date
November 1 2015
End Date
April 19 2018
Last Update
November 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.